Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 12,085 More Arrow 13,886 Less Arrow 3,313
Financial expenses 9,510 Less Arrow 4,371 Less Arrow 119
Earnings before taxes -74,875 More Arrow -54,813 More Arrow -53,597
EBITDA -70,176 More Arrow -52,891 Less Arrow -53,484
Total assets 91,748 More Arrow 151,632 Less Arrow 99,034
Current assets 77,068 More Arrow 144,200 Less Arrow 92,143
Current liabilities 28,928 Less Arrow 23,787 Less Arrow 16,742
Equity capital -15,129 More Arrow 54,178 More Arrow 74,077
- share capital 4,960 Less Arrow 4,945 Less Arrow 4,531
Employees (average) 159 Less Arrow 144 Less Arrow 116

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency -16.5% More Arrow 35.7% More Arrow 74.8%
Turnover per employee 76 More Arrow 96 Less Arrow 29
Profit as a percentage of turnover -619.6% More Arrow -394.7% Less Arrow -1617.8%
Return on assets (ROA) -71.2% More Arrow -33.3% Less Arrow -54.0%
Current ratio 266.4% More Arrow 606.2% Less Arrow 550.4%
Return on equity (ROE) 494.9% Less Arrow -101.2% More Arrow -72.4%
Change turnover -1,841 More Arrow 10,841 Less Arrow 2,716
Change turnover % -13% More Arrow 356% More Arrow 456%
Chg. No. of employees 15 More Arrow 28 More Arrow 34
Chg. No. of employees % 10% More Arrow 24% More Arrow 41%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.